E

Enzymatica AB (publ)
STO:ENZY

Watchlist Manager
Enzymatica AB (publ)
STO:ENZY
Watchlist
Price: 1.8 SEK 3.45% Market Closed
Market Cap: 436.9m SEK
Have any thoughts about
Enzymatica AB (publ)?
Write Note

Intrinsic Value

The intrinsic value of one ENZY stock under the Base Case scenario is 1.83 SEK. Compared to the current market price of 1.8 SEK, Enzymatica AB (publ) is Undervalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENZY Intrinsic Value
1.83 SEK
Undervaluation 2%
Intrinsic Value
Price
E
Base Case Scenario

Valuation Backtest
Enzymatica AB (publ)

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ENZY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ENZY?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Enzymatica AB (publ)

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Enzymatica AB (publ)

Provide an overview of the primary business activities
of Enzymatica AB (publ).

What unique competitive advantages
does Enzymatica AB (publ) hold over its rivals?

What risks and challenges
does Enzymatica AB (publ) face in the near future?

Has there been any significant insider trading activity
in Enzymatica AB (publ) recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enzymatica AB (publ).

Provide P/S
for Enzymatica AB (publ).

Provide P/E
for Enzymatica AB (publ).

Provide P/OCF
for Enzymatica AB (publ).

Provide P/FCFE
for Enzymatica AB (publ).

Provide P/B
for Enzymatica AB (publ).

Provide EV/S
for Enzymatica AB (publ).

Provide EV/GP
for Enzymatica AB (publ).

Provide EV/EBITDA
for Enzymatica AB (publ).

Provide EV/EBIT
for Enzymatica AB (publ).

Provide EV/OCF
for Enzymatica AB (publ).

Provide EV/FCFF
for Enzymatica AB (publ).

Provide EV/IC
for Enzymatica AB (publ).

Show me price targets
for Enzymatica AB (publ) made by professional analysts.

What are the Revenue projections
for Enzymatica AB (publ)?

How accurate were the past Revenue estimates
for Enzymatica AB (publ)?

What are the Net Income projections
for Enzymatica AB (publ)?

How accurate were the past Net Income estimates
for Enzymatica AB (publ)?

What are the EPS projections
for Enzymatica AB (publ)?

How accurate were the past EPS estimates
for Enzymatica AB (publ)?

What are the EBIT projections
for Enzymatica AB (publ)?

How accurate were the past EBIT estimates
for Enzymatica AB (publ)?

Compare the revenue forecasts
for Enzymatica AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enzymatica AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enzymatica AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enzymatica AB (publ) compared to its peers.

Compare the P/E ratios
of Enzymatica AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Enzymatica AB (publ) with its peers.

Analyze the financial leverage
of Enzymatica AB (publ) compared to its main competitors.

Show all profitability ratios
for Enzymatica AB (publ).

Provide ROE
for Enzymatica AB (publ).

Provide ROA
for Enzymatica AB (publ).

Provide ROIC
for Enzymatica AB (publ).

Provide ROCE
for Enzymatica AB (publ).

Provide Gross Margin
for Enzymatica AB (publ).

Provide Operating Margin
for Enzymatica AB (publ).

Provide Net Margin
for Enzymatica AB (publ).

Provide FCF Margin
for Enzymatica AB (publ).

Show all solvency ratios
for Enzymatica AB (publ).

Provide D/E Ratio
for Enzymatica AB (publ).

Provide D/A Ratio
for Enzymatica AB (publ).

Provide Interest Coverage Ratio
for Enzymatica AB (publ).

Provide Altman Z-Score Ratio
for Enzymatica AB (publ).

Provide Quick Ratio
for Enzymatica AB (publ).

Provide Current Ratio
for Enzymatica AB (publ).

Provide Cash Ratio
for Enzymatica AB (publ).

What is the historical Revenue growth
over the last 5 years for Enzymatica AB (publ)?

What is the historical Net Income growth
over the last 5 years for Enzymatica AB (publ)?

What is the current Free Cash Flow
of Enzymatica AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enzymatica AB (publ).

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Enzymatica AB (publ)

Current Assets 128.5m
Cash & Short-Term Investments 96.9m
Receivables 19.3m
Other Current Assets 12.4m
Non-Current Assets 83.4m
Long-Term Investments 2.4m
PP&E 14.3m
Intangibles 66.7m
Other Non-Current Assets 1k
Current Liabilities 10.9m
Accounts Payable 9.7m
Other Current Liabilities 1.2m
Non-Current Liabilities 11.5m
Long-Term Debt 1.3m
Other Non-Current Liabilities 10.2m
Efficiency

Earnings Waterfall
Enzymatica AB (publ)

Revenue
44.2m SEK
Cost of Revenue
-14.9m SEK
Gross Profit
29.4m SEK
Operating Expenses
-81.5m SEK
Operating Income
-52.1m SEK
Other Expenses
-1.8m SEK
Net Income
-54m SEK

Free Cash Flow Analysis
Enzymatica AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ENZY Profitability Score
Profitability Due Diligence

Enzymatica AB (publ)'s profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Declining ROIC
18/100
Profitability
Score

Enzymatica AB (publ)'s profitability score is 18/100. The higher the profitability score, the more profitable the company is.

ENZY Solvency Score
Solvency Due Diligence

Enzymatica AB (publ)'s solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Enzymatica AB (publ)'s solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENZY Price Targets Summary
Enzymatica AB (publ)

Wall Street analysts forecast ENZY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENZY is 3.96 SEK with a low forecast of 2.71 SEK and a high forecast of 5.34 SEK.

Lowest
Price Target
2.71 SEK
50% Upside
Average
Price Target
3.96 SEK
120% Upside
Highest
Price Target
5.34 SEK
197% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ENZY?

Click here to dive deeper.

Dividends

Enzymatica AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for ENZY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ENZY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Enzymatica AB (publ)

Country

Sweden

Industry

Pharmaceuticals

Market Cap

436.9m SEK

Dividend Yield

0%

Description

Enzymatica AB engages in the research, development, and sale of medical technology products. The company is headquartered in Lund, Skane and currently employs 26 full-time employees. The company went IPO on 2011-06-14. The company researches, develops and registers enzyme-based health and wellbeing products. The firm uses a patented enzyme, Penzyme, a cold-adapted trypsin from deep sea cod. The enzyme is active at about 37 Celsius degree and decomposes disease-related proteins, counteracting viral and bacterial infections and supporting healing processes. The firm conducts clinical studies of ColdZyme Munspray, a cold medicine. The company operates such subsidiaries, as Enzymatica Care AB, Zymetech ehf, among others. Main shareholders of Enzymatica AB are Humea AB, Medi AB, and Nordic Consulting Group AB, among others. In November 2013, the Company established another subsidiary in the United States, Enzymatica North America Inc., responsible for future production and sale of veterinary products in the United States and Canada.

Contact

SKANE
Lund
Ideon Science Park, Scheelevagen 19
+46462863100.0
www.enzymatica.se

IPO

2011-06-14

Employees

26

Officers

Chief Executive Officer
Mr. Claus Egstrand
CFO & Deputy CEO
Ms. Therese Filmersson
Director of Operations
Ms. Malin Richter
Commercial Director
Mr. Chris Czyrko

See Also

Discover More
What is the Intrinsic Value of one ENZY stock?

The intrinsic value of one ENZY stock under the Base Case scenario is 1.83 SEK.

Is ENZY stock undervalued or overvalued?

Compared to the current market price of 1.8 SEK, Enzymatica AB (publ) is Undervalued by 2%.

Back to Top